Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.
about
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatmentAcute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.Scleroderma lung diseasePrognostic value of serum growth differentiation factor-15 in patients with chronic obstructive pulmonary disease exacerbationGrowth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort studyPractical approach to screening for scleroderma-associated pulmonary arterial hypertension.Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Novel serum biomarkers in pulmonary arterial hypertension.Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data.Biomarkers in connective tissue diseases.Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data.Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach.
P2860
Q26995542-74725E3E-0A4A-4572-9684-FCBA8F192148Q30371420-A2F60D06-2594-4300-9C90-3B1F3BD8C351Q33891553-84CCC3E5-3DD7-4046-AF57-3019FE470224Q33919119-B99BCE1E-7017-4E7D-8254-DE32F0392C0CQ34865585-076EBB87-5216-4BC6-A032-76C5EB0B3DDCQ36997947-D81EDC68-A691-492B-BDEF-533BE419A513Q37955130-47056BA4-E357-49CF-AD62-2856FCAD0BB8Q38156227-073A3DA3-1677-4DB2-B2E9-1BD22A3D2B7DQ38262569-9CD83F9D-8630-436B-A180-6F9D3CC26FFEQ46605188-2EE5309B-1AB7-475D-A9C8-841048C3609CQ47314399-BD104234-EB9C-428B-89AE-143F2FB00F2FQ49089937-51AB4BC6-9269-4C5E-ADD7-00C5799A5F09Q52868225-19FE2D7B-7DA0-454E-8B43-FA4949CAA532Q53728725-AAF2D0E3-BE59-430D-9765-5DB5C86AE094Q55285033-0BBE932C-384D-463B-9B5E-97149DEB3B74Q55499525-A62D4780-0EF1-486E-8AB8-4EEEFEBF1CFF
P2860
Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased expression of growth ...... lmonary arterial hypertension.
@ast
Increased expression of growth ...... lmonary arterial hypertension.
@en
Increased expression of growth ...... lmonary arterial hypertension.
@nl
type
label
Increased expression of growth ...... lmonary arterial hypertension.
@ast
Increased expression of growth ...... lmonary arterial hypertension.
@en
Increased expression of growth ...... lmonary arterial hypertension.
@nl
prefLabel
Increased expression of growth ...... lmonary arterial hypertension.
@ast
Increased expression of growth ...... lmonary arterial hypertension.
@en
Increased expression of growth ...... lmonary arterial hypertension.
@nl
P2093
P2860
P356
P1433
P1476
Increased expression of growth ...... lmonary arterial hypertension.
@en
P2093
Christina A Meadows
David H Collier
Mark W Geraci
Michael G Risbano
Rubin M Tuder
Todd M Bull
P2860
P304
P356
10.1378/CHEST.10-0302
P407
P577
2010-09-09T00:00:00Z